Literature DB >> 29959284

Developing a Roadmap for Interventional Oncology.

Stefan O Schoenberg1, Ulrike I Attenberger1, Stephen B Solomon2, Ralph Weissleder3,4.   

Abstract

Interventional oncology uses image-guided procedures to enhance cancer care. Today, this specialty plays an increasingly critical role in cancer diagnosis (e.g., biopsy), cancer therapy (e.g., ablation or embolization), and cancer symptom palliation (e.g., nephrostomies or biliary drainages). Although the number of procedures and technical capabilities has improved over the last few years, challenges remain. In this article we discuss the need to advance existing procedures, develop new ones, and focus on several operational aspects that will dictate future interventional techniques to enhance cancer care, particularly by accelerating drug development and improving patient outcomes. IMPLICATIONS FOR PRACTICE: Interventional oncology is vital for cancer diagnosis, therapy, and symptom palliation. This report focuses on current interventional procedures and techniques with a look toward future improvements that will improve cancer care and patient outcomes. © AlphaMed Press 2018.

Entities:  

Keywords:  Cancer; Imaging ; Intervention; Minimally invasive intervention

Mesh:

Year:  2018        PMID: 29959284      PMCID: PMC6263130          DOI: 10.1634/theoncologist.2017-0654

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  43 in total

1.  Potential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma.

Authors:  Guangfu Li; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal:  J Clin Trials       Date:  2016-04-05

2.  Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Authors:  Jip F Prince; Maurice A A J van den Bosch; Johannes F W Nijsen; Maarten L J Smits; Andor F van den Hoven; Stavros Nikolakopoulos; Frank J Wessels; Rutger C G Bruijnen; Manon N G J A Braat; Bernard A Zonnenberg; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2017-09-15       Impact factor: 10.057

3.  Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.

Authors:  Charalambos Kaittanis; Alexander Bolaender; Barney Yoo; Nilesh Shah; Ouathek Ouerfelli; Jan Grimm
Journal:  Nano Lett       Date:  2017-10-23       Impact factor: 11.189

Review 4.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.

Authors:  Jean-Charles Nault; Olivier Sutter; Pierre Nahon; Nathalie Ganne-Carrié; Olivier Séror
Journal:  J Hepatol       Date:  2017-10-13       Impact factor: 25.083

5.  Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.

Authors:  Govindarajan Narayanan; Peter J Hosein; Isabelle C Beulaygue; Tatiana Froud; Hester J Scheffer; Shree R Venkat; Ana M Echenique; Elizabeth C Hevert; Alan S Livingstone; Caio M Rocha-Lima; Jaime R Merchan; Joseph U Levi; Jose M Yrizarry; Riccardo Lencioni
Journal:  J Vasc Interv Radiol       Date:  2016-12-16       Impact factor: 3.464

6.  A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.

Authors:  Heather L McArthur; Adi Diab; David B Page; Jianda Yuan; Stephen B Solomon; Virgilio Sacchini; Christopher Comstock; Jeremy C Durack; Majid Maybody; Janice Sung; Arielle Ginsberg; Phillip Wong; Afsar Barlas; Zhiwan Dong; Chunjun Zhao; Brian Blum; Sujata Patil; Deirdre Neville; Elizabeth A Comen; Elizabeth A Morris; Alan Kotin; Edi Brogi; Y Hannah Wen; Monica Morrow; Mario E Lacouture; Padmanee Sharma; James P Allison; Clifford A Hudis; Jedd D Wolchok; Larry Norton
Journal:  Clin Cancer Res       Date:  2016-08-26       Impact factor: 12.531

7.  Histologic evolution of high-intensity focused ultrasound in rabbit muscle.

Authors:  Stephen B Solomon; Theresa L Nicol; David Y Chan; Todd Fjield; Nathaniel Fried; Louis R Kavoussi
Journal:  Invest Radiol       Date:  2003-05       Impact factor: 6.016

8.  In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies.

Authors:  Maarten L J Smits; Mattijs Elschot; Maurice A A J van den Bosch; Gerrit H van de Maat; Alfred D van het Schip; Bernard A Zonnenberg; Peter R Seevinck; Helena M Verkooijen; Chris J Bakker; Hugo W A M de Jong; Marnix G E H Lam; Johannes F W Nijsen
Journal:  J Nucl Med       Date:  2013-10-17       Impact factor: 10.057

Review 9.  Strains, Mechanism, and Perspective: Salmonella-Based Cancer Therapy.

Authors:  Cheng-Zhi Wang; Robert A Kazmierczak; Abraham Eisenstark
Journal:  Int J Microbiol       Date:  2016-04-14

Review 10.  Oncolytic Viral Therapy for Mesothelioma.

Authors:  Daniel F Pease; Robert A Kratzke
Journal:  Front Oncol       Date:  2017-08-24       Impact factor: 6.244

View more
  6 in total

Review 1.  The evolution of interventional oncology in the 21st century.

Authors:  Thomas Helmberger
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.039

Review 2.  Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors.

Authors:  Yasushi Kimura; Mario Ghosn; Waseem Cheema; Prasad S Adusumilli; Stephen B Solomon; Govindarajan Srimathveeralli
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

Review 3.  Microneedle arrays integrated with living organisms for smart biomedical applications.

Authors:  Bo Cai; Yusheng Gong; Zheng Wang; Lin Wang; Wei Chen
Journal:  Theranostics       Date:  2021-10-25       Impact factor: 11.556

Review 4.  Liquid Biopsy-Guided Interventional Oncology: A Proof of Concept with a Special Focus on Radiotherapy and Radiology.

Authors:  Natalia Malara; György Kovacs; Francesco Bussu; Teresa Ferrazzo; Virginia Garo; Cinzia Raso; Patrizia Cornacchione; Roberto Iezzi; Luca Tagliaferri
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

5.  Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.

Authors:  Bo Franzén; Kristina Viktorsson; Caroline Kamali; Eva Darai-Ramqvist; Vitali Grozman; Vasiliki Arapi; Petra Hååg; Vitaliy O Kaminskyy; Per Hydbring; Lena Kanter; Sven Nyrén; Simon Ekman; Luigi De Petris; Rolf Lewensohn
Journal:  Mol Oncol       Date:  2021-05-01       Impact factor: 6.603

6.  CIRSE Clinical Practice Manual.

Authors:  Andreas H Mahnken; Esther Boullosa Seoane; Allesandro Cannavale; Michiel W de Haan; Rok Dezman; Roman Kloeckner; Gerard O'Sullivan; Anthony Ryan; Georgia Tsoumakidou
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-06       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.